1. Targeting CDK9 for the Treatment of Glioblastoma
   Alice Ranjan et al, 2021, Cancers CrossRef
2. Application of Sensitivity Analysis to Discover Potential Molecular Drug Targets
   Malgorzata Kardynska et al, 2022, International Journal of Molecular Sciences CrossRef
3. Cyclin-dependent kinase inhibitors in head and neck cancer and glioblastoma—backbone or add-on in immune-oncology?
   Christin Riess et al, 2021, Cancer and Metastasis Reviews CrossRef
4. Recent Discovery and Development of Inhibitors that Target CDK9 and Their Therapeutic Indications
   Yuming Zhang et al, 2024, Journal of Medicinal Chemistry CrossRef
5. Harnessing type I interferon-mediated immunity to target malignant brain tumors
   Juhee Lim et al, 2023, Frontiers in Immunology CrossRef